NEW YORK (GenomeWeb News) — Heiner Dreismann has been named to the board of directors at Nanogen, the company said this week.
 
Dreismann is the current CEO of FasTraQ and previously served as president and CEO of Roche Molecular Systems
 
Dreismann became a director of Iconix Biosciences last week and last month became a director of GeneNews, formerly ChondroGene.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.